Yuji Oikawa Selected Research

Yuji Oikawa Research Topics

Disease

14	Heart Failure 05/2024 - 01/2002
13	Atrial Fibrillation 02/2023 - 01/2012
9	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 10/2009
8	Myocardial Infarction 05/2024 - 01/2013
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 03/2011
6	Chronic Renal Insufficiency 03/2024 - 01/2013
5	Acute Coronary Syndrome 05/2024 - 10/2015
5	Thrombosis (Thrombus) 01/2022 - 10/2009
5	Death (Near-Death Experience) 10/2018 - 10/2009
4	Hemorrhage 01/2020 - 01/2012
4	Dyslipidemias (Dyslipidemia) 02/2019 - 08/2013
3	Stroke (Strokes) 05/2024 - 01/2022
3	Hypertension (High Blood Pressure) 04/2024 - 11/2014
3	Ischemic Stroke 09/2020 - 08/2017
3	Thromboembolism 01/2020 - 01/2016
3	Diabetes Mellitus 01/2015 - 09/2012
3	Obesity 07/2014 - 07/2013
3	Gout 06/2014 - 11/2009
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 08/2017
2	Hyperuricemia 06/2014 - 01/2014
2	Anemia 08/2013 - 09/2012
2	Heart Diseases (Heart Disease) 09/2012 - 01/2012
1	Neoplasms (Cancer) 05/2024
1	Myocarditis (Carditis) 05/2024
1	Aortic Dissection 05/2024
1	Pericarditis 05/2024
1	Bone Fractures (Bone Fracture) 09/2021
1	Spasm (Spasms) 04/2020
1	Myocardial Bridging 04/2020
1	Atherosclerosis 08/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2013
1	Stable Angina 01/2013
1	Pathologic Constriction (Stenosis) 01/2013
1	Angina Pectoris 03/2010
1	Muscle Spasticity (Spastic) 03/2010
1	ST Elevation Myocardial Infarction 01/2010
1	Cerebral Hemorrhage 10/2009
1	Type IV Ehlers-Danlos Syndrome 06/2009
1	Cardiogenic Shock 06/2009
1	Ventricular Fibrillation 06/2009
1	Aneurysm (Aneurysms) 04/2008
1	Tachycardia (Tachyarrhythmias) 06/2005

Drug/Important Bio-Agent (IBA)

7	omega-Chloroacetophenone (Mace)IBA 10/2018 - 10/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2019 - 03/2011
5	Uric Acid (Urate)IBA 06/2014 - 11/2009
4	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 11/2014
3	CreatinineIBA 06/2022 - 01/2020
3	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 12/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 01/2013
3	Dabigatran FDA Link 01/2015 - 01/2012
2	AnticoagulantsIBA 09/2020 - 01/2016
2	Bisoprolol (Concor)FDA LinkGeneric 07/2020 - 04/2020
2	RivaroxabanIBA 01/2020 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 09/2012
2	Everolimus FDA Link 01/2016 - 06/2014
1	fibrin fragment D (D-dimer)IBA 04/2024
1	Contrast MediaIBA 09/2023
1	Alkaline PhosphataseIBA 02/2023
1	Pharmaceutical Sleep AidsIBA 11/2022
1	LDL CholesterolIBA 06/2022
1	Ergonovine (Ergometrine)IBA 04/2020
1	AlbuminsIBA 01/2019
1	Carbon DioxideIBA 01/2018
1	SmokeIBA 08/2017
1	HDL CholesterolIBA 07/2014
1	Insulin (Novolin)FDA Link 07/2014
1	urate transporterIBA 01/2013
1	DiureticsIBA 09/2012
1	Syntex adjuvant formulationIBA 01/2012
1	CollagenIBA 08/2010
1	FibrinIBA 08/2010
1	benidipineIBA 03/2010
1	Nifedipine (Adalat)FDA LinkGeneric 03/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2010
1	Ticlopidine (Ticlid)FDA LinkGeneric 01/2010
1	alpha Adrenergic ReceptorsIBA 06/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2005
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2002
1	Adenosine (Adenocard)FDA LinkGeneric 01/2002

Therapy/Procedure

11	Percutaneous Coronary Intervention 05/2024 - 04/2008
7	Stents 01/2022 - 10/2009
7	Therapeutics 12/2017 - 06/2009
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2024 - 01/2010
2	Polypharmacy 11/2021 - 09/2021
2	Drug-Eluting Stents 07/2014 - 01/2013
1	Radiotherapy 05/2024
1	Renal Dialysis (Hemodialysis) 06/2022
1	Injections 04/2020
1	Patient Readmission 01/2015
1	Secondary Prevention 03/2011